Cell Free Hemoglobin and the Pathogenesis of ARDS

Size: px
Start display at page:

Download "Cell Free Hemoglobin and the Pathogenesis of ARDS"

Transcription

1 Cell Free Hemoglobin and the Pathogenesis of ARDS New therapeutic target? Lorraine B. Ware M.D. Vanderbilt University Nashville, TN Financial disclosures: Dr. Ware receives research funding from Boehringer Ingelheim and Global Blood Therapeutics unrelated to this presentation

2 Intra-alveolar hemorrhage is a prominent feature of ARDS

3 Are red blood cells more than innocent bystanders in the pathogenesis of ARDS and sepsis?

4 Method for Sampling Pulmonary Edema Fluid 14 Fr Tracheal suction catheter Gentle aspiration of alveolar edema

5 Edema Fluid Hemoglobin (mg/dl) Edema Fluid Hemoglobin (mg/dl) Cell-free hemoglobin levels are elevated in the airspace in ARDS * P = P p = 0.17 n = 9 n = 14 Hospital Mortality Bastarache et al. Thorax 67:1032-9, 2012

6 In-Hospital Mortality (%) In 391 patients with severe sepsis, plasma levels of free hemoglobin are associated with hospital mortality * P = *p = Undetectable (n = 75) mg/dl (n = 118) mg/dl (n = 68) 30 mg/dl (n = 130) Plasma Free Hemoglobin Janz DR et al, Crit Care Med 2013

7 Cell-Free Hemoglobin potent vasoconstrictor binds nitric oxide Hemoglobin mediates vascular injury in hemolytic states such as sickle cell disease Ferryl (4 + ) hemoglobin may be a critical mediator of injury Globin Heme Ferrous 2+ Hyperoxia H 2 O 2 RO S Ferric 3+ Ferryl 4+

8 Ferryl-Hemoglobin in Pulmonary Edema Fluid Measured by EPR Positive Control for Ferryl-Hemoglobin Protein Radical Ferryl hemoglobin can be detected in pulmonary Ferryl-hemoglobin edema Ferryl-Hemoglobin fluid in Hemoglobin Pulmonary from Edema ARDS Fluid Measured patients by EPR A by EPR Positive Control for Ferryl-Hemoglobin + H 2 O 2 Protein Radical B Ferryl-hemoglobin Hemoglobin + HHemoglobin 2 O 2 Ferryl-Hemoglobin B A - A Hemoglobin + H 2 O 2 Human Pulmonary Fluid Hemoglobin Ferryl-Hemoglobin Transferrin + H 2 O 2 hpef_v1003_ef2 Human hpef_v0207_ef1 Pulmonary Fluid Transferrin hpef_v0804_ef2 hpef_v1003_ef2 hpef_v0207_ef1 hpef_v0306_ef B B - A C D C E D F Hydrostatic Edema Fluid ARDS Edema Fluid Methemoglobin hpef_v0804_ef2 Ferryl-hemoglobin E Methemoglobin hpef_v0306_ef Magnetic Field, Gauss EPR Spectra Ferryl-hemoglobin Magnetic Field, Gauss F

9 In mice, cell-free hemoglobin is released into the airspace in ventilator and pneumonia-induced ARDS VILI Model * P < 0.03 vs others * Pneumonia Model * P = 0.05 * * Shaver CM et al, AJP Lung 2016, 310(6):L532-41

10 BAL Cell Count (x 100,000/ml) BAL Protein (ug/ml) Intra-tracheal instillation of cell-free hemoglobin causes lung inflammation and increased permeability * * P = * P < * Control Cell-free hemoglobin Control Cell-free hemoglobin PBS CF-Hgb Shaver CM et al, AJP Lung 2016, 310(6):L532-41

11 BAL Protein (ug/ml) BAL Cell Count (x100,000/ml) *" B Intravenous cellfree hemoglobin potentiates mortality and ALI in sepsis due to peritonitis ** C A * P = A * * * B B ** ** * P = * Slurry Slurry + Hemoglobin Slurry Slurry + Hemoglobin

12 Isolated perfused human lung model + Evans Blue-labeled Albumin + cell-free hemoglobin

13 Cell-free hemoglobin (CFH) in the perfusate increases vascular permeability in the isolated human lung N = 5 per group, * p = N = 5 per group, * p = 0.027

14 Hyperoxia potentiates the effect of cell-free hemoglobin on vascular permeability CFH in Paired Donor Lungs 21% vs 95% FiO2 N = 5 lung pairs, *p =0.043 N = 5 lung pairs, *p =0.043

15 Acetaminophen is a specific hemoprotein reductant that reduces oxidized hemoglobin!

16 In the human lung, acetaminophen (APAP) prevents cell-free hemoglobin/hyperoxia induced vascular permeability n=6 per group n=6 per group

17 ACROSS Trial: ACetaminophen for the Reduction of Oxidative Stress in Sepsis Phase IIa randomized placebo-controlled clinical trial 40 patients with severe sepsis Acetaminophen 1g enterally q6h vs. placebo Primary outcome: plasma F2 isoprostane levels Secondary outcomes: organ dysfunction, ventilator-free days, mortality Janz et al Crit Care Med. 2015;43:534-41

18 lity of Survival ility of Survival Ferryl-Hgb (Arbitrary Units) Ferryl-Hgb (Arbitrary Units) Plasma F2-Isoprostanes (pg/ml) Plasma F2-Isoprostanes (pg/ml) Creatinine (mg/dl) Creatinine (mg/dl) 48 hour treatment with acetaminophen reduces plasma ferryl (4+) hemoglobin and lipid peroxidation products in severe sepsis A A B B p = p = p = 0.04 p = C 3 2 C * p = 0.04 * p = * p * p = 0.01 * p H Study Day Study Day Com D D 100 Acetaminop Ac 100 Placebo Placebo APAP APAP Placebo Placebo APAP APAP Janz et al Crit Care Med. 2015;43:

19 Probability of Survival Probability of Survival Ferryl-Hgb (Arbitrary Units) Plasma F2-Isoprostanes (pg/ml) Plasma F2-Isoprostanes (pg/ml) Creatinine (mg/dl) Creatinine (mg/dl) A Placebo p = p = Placebo APAP Acetaminophen reduces serum creatinine and has no adverse effects on mortality in Placebo severe sepsis APAP B B Placebo p = 0.04 p = 0.04 APAP APAP 3 3 C C Placebo Acetaminophen * p = Placebo Acetaminophen * p = * p = 0.01 * p = 0.01 * p = * p = * p = * p = Highest At Discharge 0 After or Death 0 1 Study 2 Day Completion Highest At Discharge D Study Day After or Death Acetaminophen 100 Completion D Acetaminophen Placebo Days Placebo Days p = p = Janz et al Crit Care Med. 2015;43:534-41

20 PARACETAMOL EFFECT ON RENAL FUNCTION IN SEVERE AND MODERATELY SEVERE FALCIPARUM MALARIA WITH INTRAVASCULAR HAEMOLYSIS: A RANDOMISED CONTROLLED TRIAL KATHERINE PLEWES ET AL. HYPOTHESIS: Paracetamol will reduce kidney dysfunction in patients with severe and moderately severe malaria complicated by intravascular haemolysis Ramu

21 PARACETAMOL REDUCES RISK OF DEVELOPING AKI

22 PARACETAMOL REDUCES CREATININE IN PATIENTS WITH ELEVATED CELL-FREE HAEMOGLOBIN All patients High CFH Low CFH

23 Summary Cell-free hemoglobin is present both in the circulation and the airspace in patients with ARDS and sepsis Studies in mice suggest that cell-free hemoglobin may potentiate both pulmonary and nonpulmonary organ dysfunction in ARDS and sepsis In vitro, cell-free hemoglobin increases endothelial and epithelial permeability Therapies that target free hemoglobin may be beneficial in ARDS and sepsis

24 Red blood cells more than innocent bystanders Release of cell-free hemoglobin in both the circulation and the airspace potentiates ARDS and other organ dysfunction and is a potential therapeutic target

25 Funding NIH, Vanderbilt Institute for Clinical and Translational Research UCSF Michael Matthay Carolyn Calfee Kathleen Liu LSU New Orleans David Janz Vanderbilt Julie Bastarache Ciara Shaver Shaina Johnson Eric Kerchberger Nathan Putz Stuart Landstreet Brennan McNeil Nancy Wickersham Anna Reding Melinda Paul Sergey Dikalov James May Josh Fessell Jack Roberts John Oates Tatsuki Koyama Zhiguo Zhao Gordon Bernard Addison May

Is ARDS Important to Recognize?

Is ARDS Important to Recognize? Is ARDS Important to Recognize? Lorraine B. Ware MD Vanderbilt University Financial Disclosures: research funding from Boehringer Ingelheim, Global Blood Therapeutics Why diagnose ARDS? -initiate specific

More information

Novel pharmacotherapy in ARDS

Novel pharmacotherapy in ARDS Novel pharmacotherapy in ARDS Danny McAuley Royal Victoria Hospital and Queen s University of Belfast Critical Care Cananda Forum October 2012 Disclosures GSK; consultancy and participate in research funded

More information

7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability

7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Identify the 5 criteria for the diagnosis of ARDS. Discuss the common etiologies

More information

The GOLD Study. Goal of Open Lung Ventilation in Donors. Michael A. Matthay M.D. and Lorraine B. Ware, MD. Disclosures

The GOLD Study. Goal of Open Lung Ventilation in Donors. Michael A. Matthay M.D. and Lorraine B. Ware, MD. Disclosures The GOLD Study Goal of Open Lung Ventilation in Donors Michael A. Matthay M.D. and Lorraine B. Ware, MD Disclosures Research grants from the NHLBI, FDA & Industry - R37 HL51856 - R01 HL126176 - HL 110969

More information

ACUTE RESPIRATORY DISTRESS SYNDROME

ACUTE RESPIRATORY DISTRESS SYNDROME ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe

More information

Translating Genetic Risk into ALI Therapeutics. Nuala J. Meyer, MD MS November 16, 2011

Translating Genetic Risk into ALI Therapeutics. Nuala J. Meyer, MD MS November 16, 2011 Translating Genetic Risk into ALI Therapeutics Nuala J. Meyer, MD MS November 16, 2011 Presenter Disclosures: N. Meyer Personal financial relationships None Financial support from non-commercial sources

More information

Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS

Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS [ Original Research ] Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS Katherine DesPrez, BA; J. Brennan McNeil, BS; Chunxue Wang, PhD; Julie A. Bastarache, MD; Ciara M. Shaver, MD, PhD;

More information

Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress

Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress 1 Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA 2 Department of Veterans Affairs Medical Center, Nashville, Tennessee,

More information

How can human models of ALI inform clinical trials

How can human models of ALI inform clinical trials How can human models of ALI inform clinical trials Danny McAuley Royal Victoria Hospital and Queen s University of Belfast Critical Care Cananda Forum October 2012 Disclosures GSK; consultancy and participate

More information

Acute Respiratory Failure. Respiratory Failure. Respiratory Failure. Acute Respiratory Failure. Ventilatory Failure. Type 1 Respiratory Failure

Acute Respiratory Failure. Respiratory Failure. Respiratory Failure. Acute Respiratory Failure. Ventilatory Failure. Type 1 Respiratory Failure Acute Respiratory Failure Physiologic Classification Acute Respiratory Failure Type 1 Hypoxemic Type 2 Ventilatory Type 3 Post-op Type 4 Shock Mechanism Shunt Va Atelectasis Cardiac Output Phil Factor,

More information

Intravenous Vitamin C. Severe Sepsis Acute Lung Injury

Intravenous Vitamin C. Severe Sepsis Acute Lung Injury Intravenous Vitamin C Severe Sepsis Acute Lung Injury Alpha A. (Berry) Fowler, III, MD Professor of Medicine VCU Pulmonary Disease and Critical Care Medicine I Have No Disclosures Bacterial Sepsis Approximately

More information

Effect of ARDS Severity and Etiology on Short-Term Outcomes

Effect of ARDS Severity and Etiology on Short-Term Outcomes Effect of ARDS Severity and Etiology on Short-Term Outcomes Haitham El-Haddad MD, Hyejeong Jang MSc, Wei Chen PhD, and Ayman O Soubani MD BACKGROUND: We evaluated the outcome of subjects with ARDS in relation

More information

Fluid restriction is superior in acute lung injury and ARDS

Fluid restriction is superior in acute lung injury and ARDS TAKE-HOME POINTS FROM LECTURES BY CLEVELAND CLINIC AND VISITING FACULTY MEDICAL GRAND ROUNDS CME CREDIT HERBERT P. WIEDEMANN, MD Chairman, Department of Pulmonary, Allergy, and Critical Care Medicine,

More information

Index. Note: Page numbers of article titles are in boldface type

Index. Note: Page numbers of article titles are in boldface type Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.

More information

ARDS Endotypes and Phenotypes

ARDS Endotypes and Phenotypes ARDS Endotypes and Phenotypes Jason D. Christie, MD, MS Associate Professor of Medicine Associate Professor of Epidemiology University of Pennsylvania School of Medicine Disclosures No relevant commercial

More information

Circulating microparticle levels are reduced in patients with ARDS

Circulating microparticle levels are reduced in patients with ARDS Shaver et al. Critical Care (2017) 21:120 DOI 10.1186/s13054-017-1700-7 RESEARCH Open Access Circulating microparticle levels are reduced in patients with ARDS Ciara M. Shaver 1, Justin Woods 1, Jennifer

More information

Class of We are pleased to provide support for the following new investigators who make up the Parker B. Francis Fellowship Class of 2016.

Class of We are pleased to provide support for the following new investigators who make up the Parker B. Francis Fellowship Class of 2016. The Parker B. Francis Fellowship Program provides career development support to M.D. and Ph.D. scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical

More information

Buffering a Permissive Hypercapnia The Evidence

Buffering a Permissive Hypercapnia The Evidence Buffering a Permissive Hypercapnia The Evidence John Laffey Department of Anesthesia, St Michael s Hospital, University of Toronto, CANADA Disclosures Funding European Research Council [FP-7] Health Research

More information

USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014

USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:

More information

Clinical syndrome of severe dyspnea of rapid onset, hypoxemia, and diffuse pulmonary infiltrates leading to respiratory failure.

Clinical syndrome of severe dyspnea of rapid onset, hypoxemia, and diffuse pulmonary infiltrates leading to respiratory failure. Yuanlin Song, M.D. Clinical syndrome of severe dyspnea of rapid onset, hypoxemia, and diffuse pulmonary infiltrates leading to respiratory failure. Pneumonia Trauma SARS PaO2/fiO2

More information

In Vivo Models and Cell Delivery for Lung Indications NO DISCLOSURES

In Vivo Models and Cell Delivery for Lung Indications NO DISCLOSURES In Vivo Models and Cell Delivery for Lung Indications Marlowe Eldridge MD Department of Pediatrics and Biomedical Engineering University of Wisconsin School of Medicine and Public Health NO DISCLOSURES

More information

Endothelial Biomarkers in Human Sepsis Pathogenesis and Prognosis for ARDS

Endothelial Biomarkers in Human Sepsis Pathogenesis and Prognosis for ARDS Endothelial Biomarkers in Human Sepsis Pathogenesis and Prognosis for ARDS Carolyn M. Hendrickson, MD, MPH 1 2, 3, 4 and Michael A. Matthay, MD 1. Department of Medicine, Division of Pulmonary and Critical

More information

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive

More information

Author: Thomas Sisson, MD, 2009

Author: Thomas Sisson, MD, 2009 Author: Thomas Sisson, MD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye Steroids in ARDS: conclusion Give low-dose steroids if indicated for another problem

More information

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology

More information

Acute Lung Injury/ARDS. Disclosures. Overview. Acute Respiratory Failure 5/30/2014. Research funding: NIH, UCSF CTSI, Glaxo Smith Kline

Acute Lung Injury/ARDS. Disclosures. Overview. Acute Respiratory Failure 5/30/2014. Research funding: NIH, UCSF CTSI, Glaxo Smith Kline Disclosures Acute Respiratory Failure Carolyn S. Calfee, MD MAS UCSF Critical Care Medicine and Trauma CME May 30, 2014 Research funding: NIH, UCSF CTSI, Glaxo Smith Kline Medical advisory boards: Cerus

More information

Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials

Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials Am J Physiol Lung Cell Mol Physiol 303: L634 L639, 2012. First published August 3, 2012; doi:10.1152/ajplung.00195.2012. CALL FOR PAPERS Translational Research in Acute Lung Injury and Pulmonary Fibrosis

More information

Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence

Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence Greg Martin, Emory University Journal Title: Critical Care Volume: Volume 4, Number Suppl 2 Publisher:

More information

The epithelium in acute lung injury/acute respiratory distress syndrome Michael A. Gropper a,b and Jeanine Wiener-Kronish a

The epithelium in acute lung injury/acute respiratory distress syndrome Michael A. Gropper a,b and Jeanine Wiener-Kronish a The epithelium in acute lung injury/acute respiratory distress syndrome Michael A. Gropper a,b and Jeanine Wiener-Kronish a a Department of Anesthesia and Perioperative Care and b Critical Care Medicine,

More information

Open Access RESEARCH. Murphy et al. Ann. Intensive Care (2017) 7:102 DOI /s y. *Correspondence:

Open Access RESEARCH. Murphy et al. Ann. Intensive Care (2017) 7:102 DOI /s y. *Correspondence: DOI 10.1186/s13613-017-0325-y RESEARCH Open Access Endothelial glycocalyx degradation is more severe in patients with non pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS

More information

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury See Editorial, p 1034 c Supplementary acknowledgements are published online only at http://thorax.bmj.com/content/ vol63/issue12 1 Department of Medicine, Division of Pulmonary and Critical Care Medicine,

More information

Acute Respiratory Distress Syndrome (ARDS) An Update

Acute Respiratory Distress Syndrome (ARDS) An Update Acute Respiratory Distress Syndrome (ARDS) An Update Prof. A.S.M. Areef Ahsan FCPS(Medicine) MD(Critical Care Medicine) MD ( Chest) Head, Dept. of Critical Care Medicine BIRDEM General Hospital INTRODUCTION

More information

Acute Kidney Injury for the General Surgeon

Acute Kidney Injury for the General Surgeon Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,

More information

SUPPLEMENTAL DIGITAL CONTENT

SUPPLEMENTAL DIGITAL CONTENT SUPPLEMENTAL DIGITAL CONTENT Manuscript titel Plasma biomarkers for Acute Respiratory Distress Syndrome: a systematic review and meta-analysis Authors 1, Matty L. Terpstra, BSc; 1, Jurjan Aman, MD; 1 Geerten

More information

Wet Lungs Dry lungs Impact on Outcome in ARDS. Charlie Phillips MD Division of PCCM OHSU 2009

Wet Lungs Dry lungs Impact on Outcome in ARDS. Charlie Phillips MD Division of PCCM OHSU 2009 Wet Lungs Dry lungs Impact on Outcome in ARDS Charlie Phillips MD Division of PCCM OHSU 2009 Today s talk Pathophysiology of ARDS The case for dry Targeting EVLW Disclosures Advisor for Pulsion Medical

More information

ARDS and Lung Protection

ARDS and Lung Protection ARDS and Lung Protection Kristina Sullivan, MD Associate Professor University of California, San Francisco Department of Anesthesia and Perioperative Care Division of Critical Care Medicine Overview Low

More information

Landmark articles on ventilation

Landmark articles on ventilation Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP

More information

Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuries

Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuries Russell et al. BMC Pulmonary Medicine (2017) 17:29 DOI 10.1186/s12890-017-0370-1 RESEARCH ARTICLE Open Access Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic

More information

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components Objectives Transfusion Pitfalls Gregory W. Hendey, MD, FACEP Professor and Chief UCSF Fresno, Emergency Medicine To list risks and benefits of various blood products To discuss controversy over liberal

More information

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures

More information

Summer 2015 Research Opportunity

Summer 2015 Research Opportunity Summer 2015 Research Opportunity Conduct research during the summer of 2015 (June 1-August 6) under the direction of a Vanderbilt scientist (stipend provided, approximately $1,800/month) Laboratory-based,

More information

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care

More information

Initiation Strategies for Renal Replacement Therapy in ICU

Initiation Strategies for Renal Replacement Therapy in ICU Initiation Strategies for Renal Replacement Therapy in ICU The Artificial Kidney Initiation in Kidney Injury trial AKIKI Stéphane Gaudry Réanimation médico-chirurgicale Hôpital Louis Mourier, Colombes

More information

Dr. Hayam Gad Associate Professor of Physiology College of Medicine King Saud University

Dr. Hayam Gad Associate Professor of Physiology College of Medicine King Saud University Dr. Hayam Gad Associate Professor of Physiology College of Medicine King Saud University INTRODUCTION Diabetic nephropathy (DN) DN is defined as the appearance of persistent clinical albuminuria in an

More information

Hemoglobin Species in Plasma of Acquired Thrombotic Thrombocytopenic Purpura Patients: A Novel Therapeutic Target?

Hemoglobin Species in Plasma of Acquired Thrombotic Thrombocytopenic Purpura Patients: A Novel Therapeutic Target? Hemoglobin Species in Plasma of Acquired Thrombotic Thrombocytopenic Purpura Patients: A Novel Therapeutic Target? Jay S. Raval 1, Yara A. Park 1, Marshall A. Mazepa 2, Swati Basu 3, Daniel B. Kim-Shapiro

More information

Sub-category: Intensive Care for Respiratory Distress

Sub-category: Intensive Care for Respiratory Distress Course n : Course 3 Title: RESPIRATORY PHYSIOLOGY, PHYSICS AND PATHOLOGY IN RELATION TO ANAESTHESIA AND INTENSIVE CARE Sub-category: Intensive Care for Respiratory Distress Topic: Acute Respiratory Distress

More information

Distant organ effects of acute kidney injury

Distant organ effects of acute kidney injury Distant organ effects of acute kidney injury Hamid Rabb Professor & Vice-Chairman Department of Medicine Johns Hopkins University Baltimore, USA Mortality with acute kidney injury- AKI With availability

More information

New Strategies in the Management of Patients with Severe Sepsis

New Strategies in the Management of Patients with Severe Sepsis New Strategies in the Management of Patients with Severe Sepsis Michael Zgoda, MD, MBA President, Medical Staff Medical Director, ICU CMC-University, Charlotte, NC Factors of increases in the dx. of severe

More information

The Berlin Definition: Does it fix anything?

The Berlin Definition: Does it fix anything? The Berlin Definition: Does it fix anything? Gordon D. Rubenfeld, MD MSc Professor of Medicine, University of Toronto Chief, Program in Trauma, Emergency, and Critical Care Sunnybrook Health Sciences Centre

More information

Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome ARDS Lung complication resulting in dangerously low blood oxygen ARDS is often a result of other health complications Clinical Manifestations Related to systemic inflammatory

More information

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT CRRT Fundamentals Pre-Test AKI & CRRT 2017 Practice Based Learning in CRRT Question 1 A 72-year-old man with HTN presents to the ED with slurred speech, headache and weakness after falling at home. He

More information

Non-cardiogenic pulmonary oedema

Non-cardiogenic pulmonary oedema Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2012 Non-cardiogenic pulmonary oedema Glaus, T M Posted at the Zurich Open

More information

ARDS: MANAGEMENT UPDATE

ARDS: MANAGEMENT UPDATE ARDS: MANAGEMENT UPDATE Tanıl Kendirli, Assoc. Prof. Ankara University School of Medicine, Pediatric Critical Care Medicine The AECC Definition Timing Acute onset, within 48-72 hours Oxygenation ALI PaO2/FiO2

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: The National Heart, Lung, and Blood Institute Acute Respiratory

More information

According to the etiology, edema may be:

According to the etiology, edema may be: What is edema? Edema : It refers to the accumulation of excess liquid in the interstitial (extracellular) spaces of a tissue or in pre-existing cavities. It may affect any organ, but most often it appears

More information

Update in Critical Care Medicine

Update in Critical Care Medicine Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update

More information

Acute Lung Injury Review

Acute Lung Injury Review REVIEW ARTICLE Acute Lung Injury Review Kenji Tsushima 1,2, Landon S. King 1, Neil R. Aggarwal 1, Antonio De Gorordo 1, Franco R. D Alessio 1 and Keishi Kubo 2 Abstract The first report of acute respiratory

More information

HEMOLYSIS AND JAUNDICE:

HEMOLYSIS AND JAUNDICE: 1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR HEMOLYSIS AND JAUNDICE: An overview

More information

Blockage of Arginine Vasopressin Receptor 2 Reduces Increase in Pulmonary Vascular Resistance in Ovine Sepsis Model

Blockage of Arginine Vasopressin Receptor 2 Reduces Increase in Pulmonary Vascular Resistance in Ovine Sepsis Model Blockage of Arginine Vasopressin Receptor 2 Reduces Increase in Pulmonary Vascular Resistance in Ovine Sepsis Model Ernesto Lopez MD 1 Osamu Fujiwara MD 1, Baigalmaa Enkhtaivan MD 1, Jose Rojas PhD 2,

More information

Extravascular lung water reflects pulmonary edema F Javier Belda MD, PhD Dept. Anesthesiology and Critical Care

Extravascular lung water reflects pulmonary edema F Javier Belda MD, PhD Dept. Anesthesiology and Critical Care 28 th ISICEM Brussels, 19 March 2008 Monitoring in respiratory failure Extravascular lung water reflects pulmonary edema F Javier Belda MD, PhD Dept. Anesthesiology and Critical Care Hospital Clinico Universitario

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, 390 391 Acid suppression in liver disease, 403 404 ACLF.

More information

Congenital Haemoglobinopathies

Congenital Haemoglobinopathies Congenital Haemoglobinopathies L. DEDEKEN, MD H O P I T A L U N I V E R S I T A I R E D E S E N F A N T S R E I N E F A B I O L A U N I V E R S I T E L I B R E DE B R U X E L L E S Red Blood Cell Disorders

More information

CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS

CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Pere Ginès, MD Liver Unit, Hospital Clínic Barcelona, Catalunya, Spain CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Hecker R and Sherlock S, The Lancet 1956 RENAL

More information

December 2012 Critical Care Case of the Month: Sepsis-like Syndrome in a Returning Traveler. Eric Chase, MD Eric Ong, MD John Bloom, MD

December 2012 Critical Care Case of the Month: Sepsis-like Syndrome in a Returning Traveler. Eric Chase, MD Eric Ong, MD John Bloom, MD December 2012 Critical Care Case of the Month: Sepsis-like Syndrome in a Returning Traveler Eric Chase, MD Eric Ong, MD John Bloom, MD University of Arizona Division of Pulmonary and Critical Care Medicine

More information

ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH

ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate Carolyn Calfee, MD MAS Mark Eisner, MD MPH June 3, 2010 Case Presentation Setting: Community hospital, November 2009 29 year old woman with

More information

A Clinico-pharmacological Study on Effect of Methylprednisolone in Acute Respiratory Distress Syndrome Patients

A Clinico-pharmacological Study on Effect of Methylprednisolone in Acute Respiratory Distress Syndrome Patients Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/135 A Clinico-pharmacological Study on Effect of Methylprednisolone in Acute Respiratory Distress Syndrome Patients

More information

ANWICU knowledge

ANWICU knowledge ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted

More information

Agonistic Autoantibodies to Angiotensin II Type I Receptor Contributes Partly to Placental Ischemia-Induced Cerebrovascular Abnormalities

Agonistic Autoantibodies to Angiotensin II Type I Receptor Contributes Partly to Placental Ischemia-Induced Cerebrovascular Abnormalities Agonistic Autoantibodies to Angiotensin II Type I Receptor Contributes Partly to Placental Ischemia-Induced Cerebrovascular Abnormalities Junie Paula Warrington 1, Fan Fan 1, Babbette B. LaMarca 1, Ralf

More information

The use of proning in the management of Acute Respiratory Distress Syndrome

The use of proning in the management of Acute Respiratory Distress Syndrome Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning

More information

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)

More information

Guideline for the Use of inhaled Nitric Oxide (NO) Catarina Silvestre Prof. Harish Vyas

Guideline for the Use of inhaled Nitric Oxide (NO) Catarina Silvestre Prof. Harish Vyas Inhaled Nitric Oxide Title of Guideline Guideline for the Use of inhaled Nitric Oxide (NO) 1a 2a 2b Contact Name and Job Title (author) Directorate & Speciality Date of submission October 2015 Date when

More information

No conflicts of interest

No conflicts of interest Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF No conflicts of interest Major Points Most ICU patients start in ED Chain of critical care starting in field and

More information

Biomarkers for ARDS not so simple. John Laffey. Critical Illness and Injury Research Centre St Michael s Hospital, University of Toronto, CANADA

Biomarkers for ARDS not so simple. John Laffey. Critical Illness and Injury Research Centre St Michael s Hospital, University of Toronto, CANADA Biomarkers for ARDS not so simple John Laffey Critical Illness and Injury Research Centre St Michael s Hospital, University of Toronto, CANADA Berlin ARDS definition - 2012 Mild Moderate Severe Acute Onset

More information

Kansas City, MO 2 University of Missouri-Kansas City, MO 3 University of Kansas School of Pharmacy,

Kansas City, MO 2 University of Missouri-Kansas City, MO 3 University of Kansas School of Pharmacy, in Acute Respiratory Distress Syndrome Joshua R. Howitt, Pharm.D. 1,2,3, John D. Hill, Pharm.D. Candidate 2, Trenton D. Nauser, M.D. 1,4 1 Department of Veterans Affairs, Kansas City, MO 2 University of

More information

Arginine as an Example of a Conditionally Essential Nutrient: Sickle Cell Disease & Trauma Claudia R. Morris MD, FAAP

Arginine as an Example of a Conditionally Essential Nutrient: Sickle Cell Disease & Trauma Claudia R. Morris MD, FAAP Arginine as an Example of a Conditionally Essential Nutrient: Sickle Cell Disease & Trauma Claudia R. Morris MD, FAAP Examining Special Nutritional Requirements in Disease States, A Workshop April 1, 2018

More information

A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy

A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy El-Orabi HA 1, Halawa MR 1, Abd El-Salam MM 1, Eliewa TF 2 and Sherif NSE 1 Internal Medicine and Endocrinology

More information

ARDS and Ventilators PG26 Update in Surgical Critical Care October 9, 2013

ARDS and Ventilators PG26 Update in Surgical Critical Care October 9, 2013 ARDS and Ventilators PG26 Update in Surgical Critical Care October 9, 2013 Pauline K. Park MD, FACS, FCCM University of Michigan School of Medicine Ann Arbor, MI OVERVIEW New Berlin definition of ARDS

More information

The 1994 North American-European Consensus Conference (NAECC) criteria:

The 1994 North American-European Consensus Conference (NAECC) criteria: Acute Lung Injury and ARDS Definitions The 1994 North American-European Consensus Conference (NAECC) criteria: Onset - Acute and persistent Radiographic criteria - Bilateral pulmonary infiltrates consistent

More information

4100: Cellular Therapy Essential Data Follow-Up Form

4100: Cellular Therapy Essential Data Follow-Up Form 4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:

More information

Nutrition and Sepsis

Nutrition and Sepsis Nutrition and Sepsis Todd W. Rice, MD, MSc Associate Professor of Medicine Vanderbilt University 2017 DNS Symposium June 2, 2017 Case 55 y.o. male COPD, DM, HTN, presents with pneumonia and septic shock.

More information

PD In Acute Kidney Injury. February 7 th -9 th, 2013

PD In Acute Kidney Injury. February 7 th -9 th, 2013 PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of

More information

NATIONAL QUALITY FORUM Renal EM Submitted Measures

NATIONAL QUALITY FORUM Renal EM Submitted Measures NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB

More information

Effects of vitamin E administration on APACHE II Score in ARDS patients

Effects of vitamin E administration on APACHE II Score in ARDS patients DARU Vol. 17, No. 1 2009 24 Effects of vitamin E administration on APACHE II Score in ARDS patients 1 Hajimahmoodi M., * 2 Mojtahedzadeh M., 2,GhaffarNatanzi N., 3 Sadrai S., 1 Sadeghi N., 4 Nadjafi A.,

More information

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,

More information

Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome Colloquium series on Integrated Systems Physiology: from molecule to function to disease Series Editors: D. Neil Granger & Joey Granger Acute Respiratory Distress Syndrome Marie Carmelle Elie Donna Carden

More information

July 3, Office of the Secretary

July 3, Office of the Secretary DEPARTMENT OF HEALTH & HUMAN SERVICES Office of the Secretary Office of Public Health and Science Office for Human Research Protections The Tower Building 1101 Wootton Parkway, Suite 200 Rockville, Maryland

More information

PETAL Network. Challenges and Opportunities. Critical Care Canada Forum Toronto. November 1, 2016

PETAL Network. Challenges and Opportunities. Critical Care Canada Forum Toronto. November 1, 2016 PETAL Network Challenges and Opportunities Critical Care Canada Forum Toronto November 1, 2016 Roy Brower, MD Johns Hopkins University Chair, PETAL Network Steering Committee PETAL Network History Objectives,

More information

WP 6 In vivo genotoxicity

WP 6 In vivo genotoxicity WP 6 In vivo genotoxicity Valérie Fessard Anses Fougères France valerie.fessard@anses.fr NANOGENOTOX Final conference 22 February 2013 WP6 partners 9 partners from 7 countries Aims Determine the in vivo

More information

5/30/2014. Pulmonary Hypertension PULMONARY HYPERTENSION. mean PAP > 25 mmhg at rest. Disclosure: none

5/30/2014. Pulmonary Hypertension PULMONARY HYPERTENSION. mean PAP > 25 mmhg at rest. Disclosure: none Disclosure: Pulmonary Hypertension none James Ramsay MD Medical Director, CV ICU, Moffitt Hospital, UCSF PULMONARY HYPERTENSION mean PAP > 25 mmhg at rest Pulmonary Hypertension and Right Ventricular Dysfunction:

More information

Study of pulmonary functions with DLco in acute respiratory distress syndrome/acute lung injury syndrome

Study of pulmonary functions with DLco in acute respiratory distress syndrome/acute lung injury syndrome International Journal of Advances in Medicine Chabukswar P et al. Int J Adv Med. 2018 Aug;5(4):882-886 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20182927

More information

PEEP recruitment maneuver

PEEP recruitment maneuver Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF Case 1: 40 yo Male restrained driver high speed MVA P 140, RR 40 labored, BP 100/70, O 2 sat 70 Chest wheeze, crackles

More information

Burn shock ( 燒燙傷休克 ) 馬偕紀念醫院整形重建外科 姚文騰醫師 2015/10/22

Burn shock ( 燒燙傷休克 ) 馬偕紀念醫院整形重建外科 姚文騰醫師 2015/10/22 Burn shock ( 燒燙傷休克 ) 馬偕紀念醫院整形重建外科 姚文騰醫師 2015/10/22 重建階梯 Sheet STSG FTSG Mesh Meek Stamp Meek Introduction Cutaneous thermal injury involving more than one-third of the total body surface area (TBSA)

More information

Acute lung injury (ALI) and its more severe. Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation

Acute lung injury (ALI) and its more severe. Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation Eur Respir J 2013; 41: 396 401 DOI: 10.1183/09031936.00004912 CopyrightßERS 2013 Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation James H. Finigan*,#,

More information

ARDS A Brief Overview. Lucas Pitts, M.D. Assistant Professor of Medicine Pulmonary and Critical Care Medicine University of Kansas School of Medicine

ARDS A Brief Overview. Lucas Pitts, M.D. Assistant Professor of Medicine Pulmonary and Critical Care Medicine University of Kansas School of Medicine ARDS A Brief Overview Lucas Pitts, M.D. Assistant Professor of Medicine Pulmonary and Critical Care Medicine University of Kansas School of Medicine Outline Definition of ARDS Epidemiology of ARDS Pathophysiology

More information

Managing an Organ - New Therapies

Managing an Organ - New Therapies Managing an Organ - New Therapies Marcelo Cypel MD MSc Canada Research Chair in Lung Transplantation Surgical Director, ECLS program UHN Assistant Professor of Surgery Division of Thoracic Surgery University

More information

Transfusion-related Acute Lung Injury (TRALI) University of California, San Francisco January 8, 2011

Transfusion-related Acute Lung Injury (TRALI) University of California, San Francisco January 8, 2011 Transfusion-related Acute Lung Injury (TRALI) Mark R. Looney, M.D. Mark R. Looney, M.D. University of California, San Francisco January 8, 2011 TRALI: Case presentation 58 year-old female with degenerative

More information

Pivotal Role of Renal Function in Acute Heart failure

Pivotal Role of Renal Function in Acute Heart failure Pivotal Role of Renal Function in Acute Heart failure Doron Aronson MD, FESC Department of Cardiology RAMBAM Health Care Campus Haifa, Israel Classification and definitions of cardiorenal syndromes CRS

More information

Advancements in Sepsis

Advancements in Sepsis Objectives Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/2016 www.fshp.org Pharmacist objectives Review recent updates in resuscitation strategies

More information

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Κωνσταντίνος Τζιόμαλος Επίκουρος Καθηγητής Παθολογίας Α Προπαιδευτική Παθολογική Κλινική, Νοσοκομείο

More information